Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents
NCT06592118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3068
Last updated 2024-09-19
Summary
This study aims to investigate the differences in clinical characteristics, causes of death, long-term survival, and surgical approaches between pediatric and adolescent follicular and papillary carcinoma by exploring data from the SEER database. The research is designed as a retrospective cohort study, primarily focused on collecting and comparing data to identify key disparities and outcomes between these two patient groups. It is anticipated that the findings will provide valuable insights into the management and prognosis of these cancers in younger populations, contributing to more targeted and effective treatment strategies.
Conditions
- Pediatric and Adolescent Differentiated Thyroid Carcinoma
- SEER Database Analysis
Interventions
- OTHER
-
Different Pathological Types (FTC vs PTC)
Comprehensive Comparison of Pediatric and Adolescent Follicular Thyroid Carcinoma and Papillary Thyroid Carcinoma Patients
Sponsors & Collaborators
-
Dezhou Hospital Qilu Hospital of Shandong University
lead OTHER
Principal Investigators
-
Tao Zhang, MD · Qilu Hospital of Shandong University Dezhou
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-01
- Primary Completion
- 2020-12-31
- Completion
- 2024-08-31
More Related Trials
-
Thyroid Cancer in United Arab Emirates
NCT04763122 ·Status: COMPLETED
-
A Clinical Study of Hyperthyroidism in Children
NCT06570967 ·Status: RECRUITING
-
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT04857086 ·Status: UNKNOWN
-
Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma
NCT02689609 ·Status: COMPLETED
-
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
NCT05819593 ·Status: NOT_YET_RECRUITING
-
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290 ·Status: UNKNOWN
-
HRQOL in Locally Advanced Thyroid Carcinoma
NCT05824312 ·Status: RECRUITING
-
HRQOL in Thyroid Cancer and Thyroid Tumours
NCT03676348 ·Status: RECRUITING
-
Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT02638077 ·Status: UNKNOWN
-
Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
NCT02156362 ·Status: UNKNOWN ·Phase: NA
-
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT06268600 ·Status: RECRUITING ·Phase: NA
-
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
NCT01150318 ·Status: COMPLETED ·Phase: NA
-
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
NCT05752604 ·Status: RECRUITING
-
Primary Care Transfer for Thyroid Cancer Patients
NCT03794375 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
NCT00181168 ·Status: COMPLETED ·Phase: PHASE2
-
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
NCT04948437 ·Status: ACTIVE_NOT_RECRUITING
-
Thyrotropin Over-suppression and Heart
NCT02645786 ·Status: COMPLETED
-
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
NCT00488644 ·Status: TERMINATED ·Phase: NA
-
Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma
NCT05593744 ·Status: COMPLETED
-
An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules
NCT01307761 ·Status: UNKNOWN
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease
NCT03566537 ·Status: COMPLETED
-
Studies on Tumors of the Thyroid
NCT00001160 ·Status: RECRUITING
-
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
NCT00085293 ·Status: COMPLETED ·Phase: PHASE2